- Home
- CYCC vs BDRX Comparison
CYCC vs BDRX Comparison
Compare CYCC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- BDRX
- Stock Information
- Founded
- CYCC 1992
- BDRX 2000
- Country
- CYCC United States
- BDRX United Kingdom
- Employees
- CYCC 12
- BDRX N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- CYCC Health Care
- BDRX Health Care
- Exchange
- CYCC Nasdaq
- BDRX Nasdaq
- Market Cap
- CYCC 2.2M
- BDRX 2.4M
- IPO Year
- CYCC N/A
- BDRX N/A
- Fundamental
- Price
- CYCC $0.36
- BDRX $4.28
- Analyst Decision
- CYCC Strong Buy
- BDRX Strong Buy
- Analyst Count
- CYCC 1
- BDRX 1
- Target Price
- CYCC $11.00
- BDRX $200.00
- AVG Volume (30 Days)
- CYCC 6.4M
- BDRX 16.1K
- Earning Date
- CYCC 11-12-2024
- BDRX 09-30-2024
- Dividend Yield
- CYCC N/A
- BDRX N/A
- EPS Growth
- CYCC N/A
- BDRX N/A
- EPS
- CYCC N/A
- BDRX N/A
- Revenue
- CYCC $74,000.00
- BDRX $104,895.00
- Revenue This Year
- CYCC N/A
- BDRX N/A
- Revenue Next Year
- CYCC $88.68
- BDRX N/A
- P/E Ratio
- CYCC N/A
- BDRX N/A
- Revenue Growth
- CYCC N/A
- BDRX N/A
- 52 Week Low
- CYCC $0.31
- BDRX $3.50
- 52 Week High
- CYCC $4.00
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- CYCC 43.22
- BDRX 47.13
- Support Level
- CYCC $0.34
- BDRX $4.13
- Resistance Level
- CYCC $0.39
- BDRX $4.60
- Average True Range (ATR)
- CYCC 0.08
- BDRX 0.25
- MACD
- CYCC 0.00
- BDRX 0.04
- Stochastic Oscillator
- CYCC 6.30
- BDRX 55.15
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.